Key result
Mas receptor blockade heightens renal vasoconstrictor responses to Angiotensin II after renal ischemia-reperfusion in hypertensive rats.
Why the study?
Renal ischemia-reperfusion (IR) injury may influence the renin-angiotensin system and hypertension, prompting investigation into renal vascular responses to Ang II with Mas receptor blockade.
Does Mas receptor blockade alter renal vascular responses to Angiotensin II in hypertensive rats following partial kidney ischemia-reperfusion?
Does Mas receptor blockade alter renal vascular responses to Angiotensin II in hypertensive rats following partial kidney ischemia-reperfusion?
Regulation of Mas receptor activity may potentially be targeted to reduce ischemic kidney complications during hypoperfusion in hypertensive states.
Answers are grounded in this paper and cite their sources.
Mas receptor blockade should not yet inform clinical decisions in hypertensive kidney injury; extends preclinical findings on renal Ang II responses but leaves open human applicability.
Background. Partial kidney ischemia-reperfusion (IR) injury is the principal cause of acute kidney injury. The renin-angiotensin system (RAS) and hypertension also may be influenced by renal IR injury. In two models of partial renal IR with and without ischemia preconditioning (IPC) and using Mas receptor (MasR) blockade, A779 or its vehicle, the renal vascular responses to angiotensin II (Ang II) administration in two-kidney-one-clip (2K1C) hypertensive rats were determined. Methods. Thirty-seven 2K1C male Wistar rats with systolic blood pressure ≥150 mmHg were randomly divided into three groups; sham, IR, and IPC + IR. The animals in the sham group underwent surgical procedures except partial IR. The rats in the IR group underwent 45 min partial kidney ischemia, and the animals in the IPC + IR group underwent two 5 min cycles of partial kidney ischemia followed by 10 min reperfusion and partial kidney ischemia for 45 min. The renal vascular responses to graded Ang II (30, 100, 300, and 1000 ng kg−1.min−1) infusion using A779 or its vehicle were measured at constant renal perfusion pressure. Results. Four weeks after 2K1C implementation, the intravenous infusion of graded Ang II resulted in dose-related increases in mean arterial pressure (MAP) ( <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>P</a:mi> </a:math> dose < 0.0001) that was not different significantly between the groups. No significant differences were detected between the groups in renal blood flow (RBF) or renal vascular resistance (RVR) responses to Ang II infusion when MasR was not blocked. However, by MasR blockade, these responses were increased in IR and IPC + IR groups that were significantly different from the sham group ( <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>P</c:mi> </c:math> < 0.05). For example, infusion of Ang II at dose 1000 ng kg−1.min−1 resulted in decreased RBF percentage change (RBF%) from the baseline to 17.5 ± 1.9%, 39.7 ± 3.8%, and 31.0 ± 3.4% in sham, IR, and IPC + IR, respectively. Conclusion. These data revealed the important role of MasR after partial kidney IR in the responses of RBF and RVR to Ang II administration in 2K1C hypertensive rats.
No takes yet. Share an insight, caveat, or question.
Karimi et al. (2021) studied Hypertension and renal ischemia-reperfusion injury (preclinical model) (n=37). Mas receptor blockade (A779) vs. Vehicle (saline) and Sham surgery was evaluated on Percentage decrease in renal blood flow (RBF%) from baseline at 1000 ng/kg/min Angiotensin II infusion (p=<0.05). Mas receptor blockade with A779 significantly increased the responses of renal blood flow and renal vascular resistance to Angiotensin II infusion after partial kidney ischemia-reperfusion in hypertensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: